The University of Chicago Header Logo

Connection

Elbert Huang to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Elbert Huang has written about Hypoglycemic Agents.
Elbert Huang
Connection Strength
6.338
Hypoglycemic Agents
  1. Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model. Med Decis Making. 2019 02; 39(2):137-151.
    View in: PubMed
    Score: 0.500
  2. Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications. Health Aff (Millwood). 2018 08; 37(8):1200-1207.
    View in: PubMed
    Score: 0.484
  3. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
    View in: PubMed
    Score: 0.463
  4. Management of diabetes mellitus in older people with comorbidities. BMJ. 2016 06 15; 353:i2200.
    View in: PubMed
    Score: 0.418
  5. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs. J Manag Care Spec Pharm. 2015 Dec; 21(12):1214-34.
    View in: PubMed
    Score: 0.402
  6. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010 Sep; 12(9):679-84.
    View in: PubMed
    Score: 0.280
  7. Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2009 Feb; 32(2):311-6.
    View in: PubMed
    Score: 0.247
  8. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006 Feb; 29(2):259-64.
    View in: PubMed
    Score: 0.204
  9. Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies. Lancet Diabetes Endocrinol. 2025 05; 13(5):427-437.
    View in: PubMed
    Score: 0.191
  10. Deprescribing in Older Adults With Type 2 Diabetes: Associations With Patients' Perspectives: The Diabetes and Aging Study. J Am Geriatr Soc. 2025 Apr; 73(4):1155-1167.
    View in: PubMed
    Score: 0.189
  11. Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population. Diabetes Obes Metab. 2024 Nov; 26(11):5261-5271.
    View in: PubMed
    Score: 0.185
  12. Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging Study. J Gen Intern Med. 2024 Oct; 39(13):2400-2406.
    View in: PubMed
    Score: 0.181
  13. Individualizing Care for Older Adults With Diabetes Amid the Revolution in Pharmacotherapy. JAMA Intern Med. 2024 Apr 01; 184(4):435-436.
    View in: PubMed
    Score: 0.179
  14. Willingness to take less medication for type 2 diabetes among older patients: The Diabetes & Aging Study. J Am Geriatr Soc. 2024 Jul; 72(7):1985-1994.
    View in: PubMed
    Score: 0.179
  15. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023 04; 176(4):eL230007.
    View in: PubMed
    Score: 0.167
  16. The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence. J Cardiovasc Transl Res. 2012 Aug; 5(4):380-7.
    View in: PubMed
    Score: 0.157
  17. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med. 2001 Dec 01; 111(8):633-42.
    View in: PubMed
    Score: 0.152
  18. The Cost and Safety of Insulin in Older Adults. JAMA Intern Med. 2021 05 01; 181(5):608-609.
    View in: PubMed
    Score: 0.146
  19. Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
    View in: PubMed
    Score: 0.133
  20. Approaches to Risk Assessment Among Older Patients With Diabetes. Curr Diab Rep. 2019 07 19; 19(8):59.
    View in: PubMed
    Score: 0.129
  21. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018 07 03; 320(1):53-62.
    View in: PubMed
    Score: 0.120
  22. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018 06; 41(6):1227-1234.
    View in: PubMed
    Score: 0.118
  23. Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use. JAMA Intern Med. 2017 10 01; 177(10):1461-1470.
    View in: PubMed
    Score: 0.114
  24. Physician perspectives on de-intensifying diabetes medications. Medicine (Baltimore). 2016 Nov; 95(46):e5388.
    View in: PubMed
    Score: 0.107
  25. Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus. J Am Geriatr Soc. 2017 01; 65(1):77-82.
    View in: PubMed
    Score: 0.106
  26. Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013. JAMA. 2016 Apr 05; 315(13):1400-2.
    View in: PubMed
    Score: 0.103
  27. Glycemic control and urinary incontinence in women with diabetes mellitus. J Womens Health (Larchmt). 2013 Dec; 22(12):1049-55.
    View in: PubMed
    Score: 0.086
  28. Medication use in older U.S. adults with diabetes mellitus and the potential ramifications of raising the glycemic target. J Am Geriatr Soc. 2011 Dec; 59(12):2381-3.
    View in: PubMed
    Score: 0.076
  29. The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus. J Am Geriatr Soc. 2011 Apr; 59(4):666-72.
    View in: PubMed
    Score: 0.073
  30. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Oct 02; 359(14):1464-76.
    View in: PubMed
    Score: 0.061
  31. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008 Aug; 10(4):310-21.
    View in: PubMed
    Score: 0.061
  32. Appropriate application of evidence to the care of elderly patients with diabetes. Curr Diabetes Rev. 2007 Nov; 3(4):260-3.
    View in: PubMed
    Score: 0.057
  33. Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: The Diabetes & Aging Study. J Am Geriatr Soc. 2023 12; 71(12):3692-3700.
    View in: PubMed
    Score: 0.043
  34. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
    View in: PubMed
    Score: 0.040
  35. The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
    View in: PubMed
    Score: 0.038
  36. Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2017 12; 40(12):1661-1667.
    View in: PubMed
    Score: 0.028
  37. Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care. 2016 Feb; 39(2):308-18.
    View in: PubMed
    Score: 0.025
  38. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.024
  39. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012 Dec; 60(12):2342-56.
    View in: PubMed
    Score: 0.020
  40. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care. 2010 Oct; 33(10):2175-7.
    View in: PubMed
    Score: 0.017
  41. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009 Nov; 32(11):1947-53.
    View in: PubMed
    Score: 0.016
  42. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009 Aug; 32(8):1378-83.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.